Januvia is the brand name for sitagliptin, a medication doctors prescribe for patients with type-2 diabetes. The purpose of the drug is to help control blood sugar levels. Since the FDA approved Januvia in 2006, doctors have prescribed the drug for millions of patients. Merck & Co., the pharmaceutical company that manufactures Januvia sells the drug in more than 80 countries.
Januvia inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which in turn extends the life of hormones that stimulate the production of insulin, causing the human body to absorb more sugar, thus avoiding unsafe levels in the bloodstream.
Unfortunately, studies have shown that Januvia’s inhibiting DPP-4, may also limit the body’s natural defense against the spread of cancerous cells.
In 2009, the U. S. Food and Drug Administration (FDA) originally warned of Januvia pancreatitis risks after the agency received 88 reports of patients who suffered pancreatitis (inflammation of the pancreas) while taking the drug in a 27-month period. Although the FDA ordered Merck to add label warnings for patients, the company was still allowed to continue selling the product.
In 2011, UCLA researchers discovered additional Januvia risks. The findings showed that individuals who take Januvia were six times more likely to develop pancreatitis, the risk of pancreatic cancer increased by 270% and thyroid cancer by 148%.
The FDA to issue a new Januvia warning in March 2013 after the Journal for the American Medical Association published a study in February 2013 that showed drugs like Januvia could double the risk for pancreatitis and lead to pancreatic cancer and kidney failure.
Merck & Co., the manufacturer of Januvia, is liable for the damages caused to patients because the company failed to warn patients about the full risks of pancreatic cancer or thyroid cancer from the prescription drug.
If you, a family member or someone you care about has been taking Januvia and are subsequently diagnosed with pancreatic cancer or thyroid cancer, you should contact a product liability attorney as soon as possible. A statute of limitations set the time you have to file a claim for damages; therefore, it is critical that you consult an attorney without delay. Because dangerous prescription drug cases are complex, it is equally important that the attorney you choose has successfully handled such cases.
The New York law firm of Rudolph F. X. Migliore, P.C., has extensive experience handling pharmaceutical product liability claims. Our firm has worked closely with nationally recognized co-counsel to obtain successful verdicts and settlements for our clients.
When we take your case, we aggressively pursue every legal measure possible to obtain full and fair compensation for the harm Januvia has caused.
Contact our Rudolph F. X. Migliore, P. C. online or call our office toll free at 1-888-980-RFXM. Arrange a consultation today. There is no cost to discuss your situation with an attorney and find out if you have grounds for a personal injury lawsuit.